Test Price
2,800 AED✅ Home Collection Available
F13A1 Gene Factor XIIIA Deficiency Genetic Test – 2,800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 15189:2022 accredited processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (available daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic post‑test guidance for result interpretation.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This analytical test examines the F13A1 gene through Next‑Generation Sequencing (NGS) to detect pathogenic variants linked to congenital Factor XIII deficiency, a rare but serious bleeding disorder. The assay covers the entire coding region and splice sites, enabling detection of point mutations, small insertions/deletions, and copy number variations.
| Feature | Our Test (NGS‑Based) | Closest Alternative (Targeted PCR) |
|---|---|---|
| Precision | Full gene sequencing with copy number variation analysis | Limited to known hotspot mutations |
| Methodology | Next Generation Sequencing (NGS) | Sanger sequencing or MLPA |
| Turnaround Time | 3 – 4 weeks | 4 – 6 weeks (often with reflex steps) |
| Diagnostic Yield | >99% for all mutation types | ~85% for point mutations only |
Physician Insight & Safety Protocols
As a Consultant Medical Genetics, I emphasize that this F13A1 gene test provides critical diagnostic clarity for patients with suspicious bleeding histories. However, results must be correlated with clinical findings and family pedigree. Our team offers comprehensive post‑test counselling to ensure informed decisions. — Lina Osama Zaki Quteineh, DHA Registration ID: 9294403
Medication Safety Advisory
Warning: Do not discontinue any prescribed hemostatic or anticoagulant therapy without consulting your physician. Sudden cessation may lead to life‑threatening hemorrhage or thrombosis. This advisory is issued in accordance with Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Recent blood transfusion (within 4 weeks) or active hemolytic episode.
- Exclusion: Known severe coagulopathy with ongoing profuse bleeding.
- Exclusion: Individuals unable to provide informed consent for genetic counselling.
- Emergency Red Flag: Sudden severe joint pain/swelling, prolonged bleeding from minor cuts, or unexplained bruising – seek immediate emergency care.
Patient FAQ & Clinical Guidance
1. What is the F13A1 gene and why is this test performed?
The F13A1 gene encodes the A subunit of coagulation factor XIII, which stabilises blood clots by cross‑linking fibrin. This test identifies pathogenic variants that cause Factor XIII deficiency, helping confirm diagnosis, guide prophylaxis, and inform family planning. A mandatory genetic counselling session is required before specimen collection.
2. How should I prepare for the blood draw, and what sample types are accepted?
A genetic counselling session to draw a family pedigree is mandatory before collection, and you must provide full clinical history. We accept whole blood (preferred), extracted DNA, or a single drop on an FTA card. No fasting is required unless other tests are bundled. Home phlebotomy is available daily from 8 AM to 11 PM.
3. When will I receive my results, and how are they delivered?
Turnaround time is 3 to 4 weeks, and the report is issued as a DHA‑compliant, encrypted PDF via your patient portal. A telephonic guidance session is included to explain variants and their clinical significance. Results are never shared over unsecured channels.
UAE Regulatory & Data Privacy Adherence
Your data is protected. DNA Labs UAE operates under the strict provisions of Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic results are encrypted, access‑controlled, and never shared without explicit patient consent. Our DHA‑approved facilities ensure full compliance with UAE data governance standards.
Clinical & Logistical Metadata
| Test Name | F13A1 Gene Factor XIIIA Deficiency Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Peripheral Whole Blood (VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection Available) |
| Methodology Used | Next Generation Sequencing (NGS) |
| ICD-10-CM Code | D68.2 |
| LOINC Code | 96737-3 |
| DHA Facility License & Laboratory Address | DHA License: 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians